Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | HMGCR | P04035 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18538616 | 0.89 | ALDH1A1 (0.52) | ALDH1A1TDP1HMGCRCHRM1TBXA2R | |
| SCHEMBL1669880 | 0.86 | ALDH1A1 (0.38) | ALDH1A1TDP1TRPA1HMGCRCHRM1 | |
| SCHEMBL14849625 | 0.83 | MGAM (0.46) | ALDH1A1LMNA | |
| SCHEMBL11090206 | 0.82 | ALDH1A1 (0.35) | ALDH1A1TDP1 | |
| SCHEMBL12836893 | 0.82 | ALDH1A1 (0.35) | ALDH1A1TDP1 | |
| SCHEMBL1667587 | 0.80 | — | — | |
| SCHEMBL13891324 | 0.79 | ALDH1A1 (0.60) | ALDH1A1TDP1HMGCRCHRM1TBXA2R | |
| SCHEMBL5145947 | 0.79 | ALDH1A1 (0.60) | ALDH1A1TDP1TRPA1HMGCRCHRM1 | |
| SCHEMBL11439849 | 0.73 | ALDH1A1 (0.41) | ALDH1A1TDP1TRPA1HMGCRCHRM1 | |
| SCHEMBL1056782 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180256105-A1 | FLEXIBLE WEARABLE DRY ELECTRODE AND PREPARATION METHOD THEREOF | SUZHOU MINDOM TECHNOLOGY CO., LTD. (CN) | 2018-09-13 | — | — | US | claimed |
| CN-108698851-B | Composition for forming coating film and method for producing same | 日产化学工业株式会社 | 2020-11-10 | — | — | CN | disclosed |
| CN-108698851-A | Composition for forming coating film and method for producing same | 日产化学工业株式会社 | 2018-10-23 | — | — | CN | disclosed |
| US-20170259099-A1 | SILICON-CONTAINING ORGANIC ACID DERIVATIVES AS ENVIRONMENTALLY FRIENDLY AFFF EXTINGUISHING AGENTS | UNIVERSITÄT ZU KÖLN (DE) | 2017-09-14 | — | — | US | disclosed |
| US-9050368-B2 | Corticosteroid compositions | MERITAGE PHARMA, INC. (US) | 2015-06-09 | — | — | US | disclosed |
| US-8911805-B2 | Calcium preparation and method of production thereof | TOYO SUISAN KAISHA, LTD. (JP) | 2014-12-16 | — | — | US | disclosed |
| US-8865692-B2 | Compositions for the treatment of gastrointestinal inflammation | MERITAGE PHARMA, INC (US) | 2014-10-21 | — | — | US | disclosed |
| US-8679545-B2 | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-03-25 | — | — | US | disclosed |
| US-8497258-B2 | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-07-30 | — | — | US | disclosed |
| US-20130022733-A1 | CALCIUM PREPARATION AND METHOD OF PRODUCTION THEREOF | TOYO SUISAN KAISHA, LTD. (JP) | 2013-01-24 | — | — | US | disclosed |
| US-20100216754-A1 | COMPOSITIONS FOR THE TREATMENT OF INFLAMMATION OF THE GASTROINTESTINAL TRACT | MERITAGE PHARMA, INC. (US) | 2010-08-26 | — | — | US | disclosed |
| US-20090191275-A1 | VISCOUS BUDESONIDE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO (US) | 2009-07-30 | — | — | US | disclosed |
| US-20090181099-A1 | TOPICAL CORTICOSTEROIDS FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO (US) | 2009-07-16 | — | — | US | disclosed |
| US-20090143343-A1 | COMPOSITIONS FOR THE TREATMENT OF INFLAMMATION OF THE GASTROINTESTINAL TRACT | MERITAGE PHARMA, INC. (US) | 2009-06-04 | — | — | US | disclosed |
| US-20090137540-A1 | COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION | MERITAGE PHARMA, INC. (US) | 2009-05-28 | — | — | US | disclosed |
| US-20090123550-A1 | CORTICOSTEROID COMPOSITIONS | MERITAGE PHARMA, INC. (US) | 2009-05-14 | — | — | US | disclosed |
| US-20090123551-A1 | GASTROINTESTINAL DELIVERY SYSTEMS | MERITAGE PHARMA, INC. (US) | 2009-05-14 | — | — | US | disclosed |
| US-20090123390-A1 | COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION | MERITAGE PHARMA, INC. (US) | 2009-05-14 | — | — | US | disclosed |
| US-20090111057-A1 | PHOTOIMAGEABLE BRANCHED POLYMER | BREWER SCIENCE INC. | 2009-04-30 | — | — | US | disclosed |
| US-7354888-B2 | Antibacterial composition and methods thereof comprising a ternary builder mixture | DANISCO A/S (DK) | 2008-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216754-A1 | COMPOSITIONS FOR THE TREATMENT OF INFLAMMATION OF THE GASTROINTESTINAL TRACT | FABP2, FABP6, PTGES2 | ALDH1A1 825/4885TDP1 4529/4885TRPA1 557/4885 |
| US-20090181099-A1 | TOPICAL CORTICOSTEROIDS FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT | TSLP, NR3C1, SERPINA6 | ALDH1A1 2041/4885TDP1 3173/4885TRPA1 1335/4885 |
| US-20090191275-A1 | VISCOUS BUDESONIDE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT | IL5, IL33, TSLP | ALDH1A1 1952/4885TDP1 3641/4885TRPA1 3424/4885 |
| US-20090123550-A1 | CORTICOSTEROID COMPOSITIONS | NR3C1, SERPINA6, NR3C2 | ALDH1A1 2311/4885TDP1 4375/4885TRPA1 2659/4885 |
| US-20090123390-A1 | COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION | FABP2, FABP6, FABP1 | ALDH1A1 1408/4885TDP1 4474/4885TRPA1 1199/4885 |
| US-20090143343-A1 | COMPOSITIONS FOR THE TREATMENT OF INFLAMMATION OF THE GASTROINTESTINAL TRACT | FABP2, FABP6, PTGES2 | ALDH1A1 825/4885TDP1 4529/4885TRPA1 557/4885 |
| US-20090137540-A1 | COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION | FABP2, FABP6, TNF | ALDH1A1 1302/4885TDP1 4485/4885TRPA1 834/4885 |
| US-20090123551-A1 | GASTROINTESTINAL DELIVERY SYSTEMS | FABP2, SLC10A2, FABP6 | ALDH1A1 2138/4885TDP1 3701/4885TRPA1 4323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.